Molecular breast imaging: A new technique using technetium Tc 99m scintimammography to detect small tumors of the breast

Deborah Rhodes, Michael K. O'Connor, Stephen W. Phillips, Robin L. Smith, Douglas A. Collins

Research output: Contribution to journalArticle

80 Citations (Scopus)

Abstract

OBJECTIVE: To determine the sensitivity of molecular breast Imaging (MBI) to detect small cancers of the breast. PATIENTS AND METHODS: A cadmium-zinc-telluride gamma camera with a field of view of 20 x 20 cm was used. The defector elements were 2.5 x 2.5 mm. The gamma camera was mounted on a modified mammographic gantry. Between November 2001 and March 2004, we performed MBI on patients who were scheduled to undergo biopsy for a lesion suggestive of malignancy that was smaller than 2 cm on a mammogram. Patients were injected with 20 mCl of technetium Tc 99m sestamibi and underwent Imaging Immediately after injection. Using light pain-free compression, we obtained cranlocaudal and mediolateral oblique views of each breast. RESULTS: Of the 40 women inducted in the study, 26 had a total of 36 malignant lesions confirmed at surgery. Of these 36 lesions, 33 were detected by MBI (overall sensitivity, 92%). Of the 22 malignant lesions 1 cm or smaller in diameter, 19 were detected by MBI (sensitivity, 36%). Two patients had false-negative MBI results. Of the 14 malignant lesions larger than 1 cm in diameter, all were identified correctly by MBI. In 4 patients, MBI identified additional lesions not seen on mammography that were confirmed subsequently on magnetic resonance imaging and were true-positive cases at surgery. Three of these patients had lesions in the breast contralaterel to the breast containing the initial mammographic finding suggestive of malignancy. Of 14 patients with no evidence of cancer at biopsy or surgery, 9 had true-negative (normal) scans and 5 had false-positive scans on MBI. False-positive results included benign fibroadenoma (2 patients), Inflammatory fat necrosis (1 patient), benign breast parenchyma (1 patient), and complex sclerosing lesion (1 patient). CONCLUSION: This prototype gamma camera system for MBI reliably detects malignant breast lesions smaller than 2 cm. Furthermore, we obtained the highest sensitivity (86%) yet reported for the detection of lesions smaller than 1 cm. These results suggest an important role for MBI, particularly for women in whom the sensitivity of mammography is reduced by the density of the breast parenchyma.

Original languageEnglish (US)
Pages (from-to)24-30
Number of pages7
JournalMayo Clinic Proceedings
Volume80
Issue number1
StatePublished - 2005

Fingerprint

Molecular Imaging
Technetium
Breast
Breast Neoplasms
Gamma Cameras
Mammography
Fat Necrosis
Technetium Tc 99m Sestamibi
Biopsy
Fibroadenoma
Neoplasms

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Molecular breast imaging : A new technique using technetium Tc 99m scintimammography to detect small tumors of the breast. / Rhodes, Deborah; O'Connor, Michael K.; Phillips, Stephen W.; Smith, Robin L.; Collins, Douglas A.

In: Mayo Clinic Proceedings, Vol. 80, No. 1, 2005, p. 24-30.

Research output: Contribution to journalArticle

Rhodes, Deborah ; O'Connor, Michael K. ; Phillips, Stephen W. ; Smith, Robin L. ; Collins, Douglas A. / Molecular breast imaging : A new technique using technetium Tc 99m scintimammography to detect small tumors of the breast. In: Mayo Clinic Proceedings. 2005 ; Vol. 80, No. 1. pp. 24-30.
@article{71cb583c7ee74e86856c10688e72844c,
title = "Molecular breast imaging: A new technique using technetium Tc 99m scintimammography to detect small tumors of the breast",
abstract = "OBJECTIVE: To determine the sensitivity of molecular breast Imaging (MBI) to detect small cancers of the breast. PATIENTS AND METHODS: A cadmium-zinc-telluride gamma camera with a field of view of 20 x 20 cm was used. The defector elements were 2.5 x 2.5 mm. The gamma camera was mounted on a modified mammographic gantry. Between November 2001 and March 2004, we performed MBI on patients who were scheduled to undergo biopsy for a lesion suggestive of malignancy that was smaller than 2 cm on a mammogram. Patients were injected with 20 mCl of technetium Tc 99m sestamibi and underwent Imaging Immediately after injection. Using light pain-free compression, we obtained cranlocaudal and mediolateral oblique views of each breast. RESULTS: Of the 40 women inducted in the study, 26 had a total of 36 malignant lesions confirmed at surgery. Of these 36 lesions, 33 were detected by MBI (overall sensitivity, 92{\%}). Of the 22 malignant lesions 1 cm or smaller in diameter, 19 were detected by MBI (sensitivity, 36{\%}). Two patients had false-negative MBI results. Of the 14 malignant lesions larger than 1 cm in diameter, all were identified correctly by MBI. In 4 patients, MBI identified additional lesions not seen on mammography that were confirmed subsequently on magnetic resonance imaging and were true-positive cases at surgery. Three of these patients had lesions in the breast contralaterel to the breast containing the initial mammographic finding suggestive of malignancy. Of 14 patients with no evidence of cancer at biopsy or surgery, 9 had true-negative (normal) scans and 5 had false-positive scans on MBI. False-positive results included benign fibroadenoma (2 patients), Inflammatory fat necrosis (1 patient), benign breast parenchyma (1 patient), and complex sclerosing lesion (1 patient). CONCLUSION: This prototype gamma camera system for MBI reliably detects malignant breast lesions smaller than 2 cm. Furthermore, we obtained the highest sensitivity (86{\%}) yet reported for the detection of lesions smaller than 1 cm. These results suggest an important role for MBI, particularly for women in whom the sensitivity of mammography is reduced by the density of the breast parenchyma.",
author = "Deborah Rhodes and O'Connor, {Michael K.} and Phillips, {Stephen W.} and Smith, {Robin L.} and Collins, {Douglas A.}",
year = "2005",
language = "English (US)",
volume = "80",
pages = "24--30",
journal = "Mayo Clinic Proceedings",
issn = "0025-6196",
publisher = "Elsevier Science",
number = "1",

}

TY - JOUR

T1 - Molecular breast imaging

T2 - A new technique using technetium Tc 99m scintimammography to detect small tumors of the breast

AU - Rhodes, Deborah

AU - O'Connor, Michael K.

AU - Phillips, Stephen W.

AU - Smith, Robin L.

AU - Collins, Douglas A.

PY - 2005

Y1 - 2005

N2 - OBJECTIVE: To determine the sensitivity of molecular breast Imaging (MBI) to detect small cancers of the breast. PATIENTS AND METHODS: A cadmium-zinc-telluride gamma camera with a field of view of 20 x 20 cm was used. The defector elements were 2.5 x 2.5 mm. The gamma camera was mounted on a modified mammographic gantry. Between November 2001 and March 2004, we performed MBI on patients who were scheduled to undergo biopsy for a lesion suggestive of malignancy that was smaller than 2 cm on a mammogram. Patients were injected with 20 mCl of technetium Tc 99m sestamibi and underwent Imaging Immediately after injection. Using light pain-free compression, we obtained cranlocaudal and mediolateral oblique views of each breast. RESULTS: Of the 40 women inducted in the study, 26 had a total of 36 malignant lesions confirmed at surgery. Of these 36 lesions, 33 were detected by MBI (overall sensitivity, 92%). Of the 22 malignant lesions 1 cm or smaller in diameter, 19 were detected by MBI (sensitivity, 36%). Two patients had false-negative MBI results. Of the 14 malignant lesions larger than 1 cm in diameter, all were identified correctly by MBI. In 4 patients, MBI identified additional lesions not seen on mammography that were confirmed subsequently on magnetic resonance imaging and were true-positive cases at surgery. Three of these patients had lesions in the breast contralaterel to the breast containing the initial mammographic finding suggestive of malignancy. Of 14 patients with no evidence of cancer at biopsy or surgery, 9 had true-negative (normal) scans and 5 had false-positive scans on MBI. False-positive results included benign fibroadenoma (2 patients), Inflammatory fat necrosis (1 patient), benign breast parenchyma (1 patient), and complex sclerosing lesion (1 patient). CONCLUSION: This prototype gamma camera system for MBI reliably detects malignant breast lesions smaller than 2 cm. Furthermore, we obtained the highest sensitivity (86%) yet reported for the detection of lesions smaller than 1 cm. These results suggest an important role for MBI, particularly for women in whom the sensitivity of mammography is reduced by the density of the breast parenchyma.

AB - OBJECTIVE: To determine the sensitivity of molecular breast Imaging (MBI) to detect small cancers of the breast. PATIENTS AND METHODS: A cadmium-zinc-telluride gamma camera with a field of view of 20 x 20 cm was used. The defector elements were 2.5 x 2.5 mm. The gamma camera was mounted on a modified mammographic gantry. Between November 2001 and March 2004, we performed MBI on patients who were scheduled to undergo biopsy for a lesion suggestive of malignancy that was smaller than 2 cm on a mammogram. Patients were injected with 20 mCl of technetium Tc 99m sestamibi and underwent Imaging Immediately after injection. Using light pain-free compression, we obtained cranlocaudal and mediolateral oblique views of each breast. RESULTS: Of the 40 women inducted in the study, 26 had a total of 36 malignant lesions confirmed at surgery. Of these 36 lesions, 33 were detected by MBI (overall sensitivity, 92%). Of the 22 malignant lesions 1 cm or smaller in diameter, 19 were detected by MBI (sensitivity, 36%). Two patients had false-negative MBI results. Of the 14 malignant lesions larger than 1 cm in diameter, all were identified correctly by MBI. In 4 patients, MBI identified additional lesions not seen on mammography that were confirmed subsequently on magnetic resonance imaging and were true-positive cases at surgery. Three of these patients had lesions in the breast contralaterel to the breast containing the initial mammographic finding suggestive of malignancy. Of 14 patients with no evidence of cancer at biopsy or surgery, 9 had true-negative (normal) scans and 5 had false-positive scans on MBI. False-positive results included benign fibroadenoma (2 patients), Inflammatory fat necrosis (1 patient), benign breast parenchyma (1 patient), and complex sclerosing lesion (1 patient). CONCLUSION: This prototype gamma camera system for MBI reliably detects malignant breast lesions smaller than 2 cm. Furthermore, we obtained the highest sensitivity (86%) yet reported for the detection of lesions smaller than 1 cm. These results suggest an important role for MBI, particularly for women in whom the sensitivity of mammography is reduced by the density of the breast parenchyma.

UR - http://www.scopus.com/inward/record.url?scp=11344261022&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=11344261022&partnerID=8YFLogxK

M3 - Article

C2 - 15667025

AN - SCOPUS:11344261022

VL - 80

SP - 24

EP - 30

JO - Mayo Clinic Proceedings

JF - Mayo Clinic Proceedings

SN - 0025-6196

IS - 1

ER -